Suat‐Cheng Peh

2.1k total citations · 1 hit paper
41 papers, 1.6k citations indexed

About

Suat‐Cheng Peh is a scholar working on Oncology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Suat‐Cheng Peh has authored 41 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 19 papers in Pathology and Forensic Medicine and 7 papers in Immunology. Recurrent topics in Suat‐Cheng Peh's work include Lymphoma Diagnosis and Treatment (17 papers), Viral-associated cancers and disorders (15 papers) and Immune Cell Function and Interaction (4 papers). Suat‐Cheng Peh is often cited by papers focused on Lymphoma Diagnosis and Treatment (17 papers), Viral-associated cancers and disorders (15 papers) and Immune Cell Function and Interaction (4 papers). Suat‐Cheng Peh collaborates with scholars based in Malaysia, Netherlands and China. Suat‐Cheng Peh's co-authors include Sin‐Yeang Teow, Jiang Gu, Jian Xu, Jingjing Yang, Xiaochun Chi, Encong Gong, Lihua Qi, Xiaohong Wei, Sibrand Poppema and Hiroshi Kimura and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Suat‐Cheng Peh

40 papers receiving 1.5k citations

Hit Papers

Pathogenic Role of Immune Cells in Rheumatoid Arthritis: ... 2018 2026 2020 2023 2018 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suat‐Cheng Peh Malaysia 17 571 337 314 313 309 41 1.6k
Sa Wang China 25 468 0.8× 596 1.8× 407 1.3× 225 0.7× 786 2.5× 84 2.7k
Tao Fu China 22 275 0.5× 379 1.1× 119 0.4× 111 0.4× 603 2.0× 85 1.8k
Carmelo Rizzari Italy 34 572 1.0× 234 0.7× 382 1.2× 177 0.6× 851 2.8× 140 3.9k
Yanhong Wang China 22 270 0.5× 109 0.3× 164 0.5× 159 0.5× 352 1.1× 96 1.8k
Tetsuro Kato Japan 33 784 1.4× 123 0.4× 171 0.5× 230 0.7× 1.2k 3.8× 140 3.2k
David Cantú de León Mexico 28 470 0.8× 61 0.2× 190 0.6× 156 0.5× 1.1k 3.6× 146 2.5k
Naohisa Tomosugi Japan 30 317 0.6× 100 0.3× 474 1.5× 158 0.5× 566 1.8× 106 2.9k
David Morgenstern United States 14 284 0.5× 242 0.7× 332 1.1× 90 0.3× 285 0.9× 26 1.4k
David K. Imagawa United States 36 547 1.0× 122 0.4× 385 1.2× 118 0.4× 428 1.4× 131 4.0k
Giuseppina M. Carbone Switzerland 29 605 1.1× 246 0.7× 167 0.5× 125 0.4× 1.6k 5.3× 67 2.5k

Countries citing papers authored by Suat‐Cheng Peh

Since Specialization
Citations

This map shows the geographic impact of Suat‐Cheng Peh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suat‐Cheng Peh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suat‐Cheng Peh more than expected).

Fields of papers citing papers by Suat‐Cheng Peh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suat‐Cheng Peh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suat‐Cheng Peh. The network helps show where Suat‐Cheng Peh may publish in the future.

Co-authorship network of co-authors of Suat‐Cheng Peh

This figure shows the co-authorship network connecting the top 25 collaborators of Suat‐Cheng Peh. A scholar is included among the top collaborators of Suat‐Cheng Peh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suat‐Cheng Peh. Suat‐Cheng Peh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ooi, Pei Boon, et al.. (2023). Knowledge of Sarcopenia and Associated Factors Among the Malaysian General Public: A Cross-sectional Study. Journal of Preventive Medicine and Public Health. 56(2). 164–171. 6 indexed citations
3.
Bradley, D.A., et al.. (2023). Low dose and low dose rate radioluminescence dosimetry. Applied Radiation and Isotopes. 198. 110875–110875. 1 indexed citations
4.
Bradley, D.A., et al.. (2022). Insights into Controlling the Spread of COVID‐19: A Study Inspired by Seven of the Earliest Vaccinated Countries. Journal of Environmental and Public Health. 2022(1). 4533957–4533957. 1 indexed citations
5.
Ramasamy, Thamil Selvee, et al.. (2021). Interplay of autophagy and cancer stem cells in hepatocellular carcinoma. Molecular Biology Reports. 48(4). 3695–3717. 16 indexed citations
6.
Izadiyan, Zahra, Kamyar Shameli, Mikio Miyake, et al.. (2018). Green fabrication of biologically active magnetic core-shell Fe3O4/Au nanoparticles and their potential anticancer effect. Materials Science and Engineering C. 96. 51–57. 65 indexed citations
7.
Hoe, Susan, Kitson Liew, Sin‐Yeang Teow, et al.. (2017). CD24, CD44 and EpCAM enrich for tumour-initiating cells in a newly established patient-derived xenograft of nasopharyngeal carcinoma. Scientific Reports. 7(1). 12372–12372. 20 indexed citations
8.
Teow, Sin‐Yeang, Kitson Liew, Alan Soo Beng Khoo, & Suat‐Cheng Peh. (2017). Pathogenic Role of Exosomes in Epstein-Barr Virus (EBV)-Associated Cancers. International Journal of Biological Sciences. 13(10). 1276–1286. 42 indexed citations
9.
Peh, Suat‐Cheng, et al.. (2013). Pattern of hMLH1, hMSH2 and hMSH6 expression and clinical characteristics in a sample of Malaysian colorectal carcinoma cases.. PubMed. 35(1). 45–57. 8 indexed citations
10.
Potu, Bhagath Kumar, et al.. (2012). Crossed-fused renal ectopia: a case report. European Journal of Anatomy. 16(1). 79–81. 2 indexed citations
11.
Peh, Suat‐Cheng, et al.. (2010). Expression and Alteration of <i>p16</i> in Diffuse Large B Cell Lymphoma. Pathobiology. 77(2). 96–105. 5 indexed citations
13.
Wong, Kah Keng, Narayanan Prepageran, & Suat‐Cheng Peh. (2008). Prognostic subgroup distribution in diffuse large B-cell lymphoma of the upper aerodigestive tract. Pathology. 41(2). 133–139. 4 indexed citations
14.
Wei, Lan, Shen Sun, Jing Zhang, et al.. (2006). Pathology of the thyroid in severe acute respiratory syndrome. Human Pathology. 38(1). 95–102. 172 indexed citations
15.
Peh, Suat‐Cheng, et al.. (2004). 18q21 Rearrangement and trisomy 3 in extranodal B-cell lymphomas: a study using a fluorescent in situ hybridisation technique. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 445(5). 506–514. 3 indexed citations
16.
Peh, Suat‐Cheng, et al.. (2004). High frequency of EBV association and 30‐bp deletion in the LMP‐1 gene in CD56+ lymphomas of the upper aerodigestive tract. Pathology International. 54(3). 158–166. 22 indexed citations
17.
Peh, Suat‐Cheng, et al.. (2004). Higher frequency of p53 gene mutations in diffuse large B‐cell lymphoma with MALT component. Pathology International. 54(11). 811–818. 3 indexed citations
18.
Peh, Suat‐Cheng, et al.. (2003). Dual variant of Epstein‐Barr virus in Hodgkin/Reed‐Sternberg cells: Single‐cell PCR study on latent membrane protein‐1 gene. International Journal of Cancer. 107(2). 250–255. 5 indexed citations
20.
Peh, Suat‐Cheng, et al.. (2002). Frequent presence of subtype A virus in Epstein–Barr virus-associated malignancies. Pathology. 34(5). 446–450. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026